[HTML][HTML] Impact of human papillomavirus vaccination, Rwanda and Bhutan

I Baussano, F Sayinzoga, U Tshomo… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Rwanda and Bhutan, 2 low-and middle-income countries, implemented primarily school-
based national human papillomavirus (HPV) vaccination in 2011 (Rwanda) and 2010 …

[HTML][HTML] Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys

F Sayinzoga, V Tenet, DAM Heideman… - The Lancet Global …, 2023 - thelancet.com
Background Rwanda was the first African country to implement national human
papillomavirus (HPV) vaccination (against types HPV6, 11, 16, and 18). In 2011, a school …

Human papillomavirus vaccine introduction–the first five years

LE Markowitz, V Tsu, SL Deeks, H Cubie, SA Wang… - Vaccine, 2012 - Elsevier
The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …

[PDF][PDF] Achieving high coverage in Rwanda's national human papillomavirus vaccination programme

A Binagwaho, CM Wagner, M Gatera… - Bulletin of the World …, 2012 - SciELO Public Health
PROBLEM: Virtually all women who have cervical cancer are infected with the human
papillomavirus (HPV). Of the 275 000 women who die from cervical cancer every year, 88 …

[HTML][HTML] Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme

F Ngabo, S Franceschi, I Baussano, MC Umulisa… - BMC infectious …, 2016 - Springer
Background Cervical cancer is the most common female cancer in Rwanda that, in 2011,
became the first African country to implement a national vaccination programme against …

[HTML][HTML] Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges

KP Msyamboza, BM Mwagomba, M Valle, H Chiumia… - BMC public health, 2017 - Springer
Background Cervical cancer is a major public health problem in Malawi. The age-
standardized incidence and mortality rates are estimated to be 75.9 and 49.8 per 100,000 …

[HTML][HTML] Human papillomavirus vaccine coverage in Rwanda: a population-level analysis by birth cohort

F Sayinzoga, MC Umulisa, H Sibomana, V Tenet… - Vaccine, 2020 - Elsevier
Abstract Background In 2011, Rwanda became the first African nation to implement a
national human papillomavirus (HPV) vaccination program, conceived to protect girls aged< …

[PDF][PDF] Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middle-income countries

DS LaMontagne, S Barge, N Thi Le… - Bulletin of the World …, 2011 - SciELO Public Health
OBJECTIVE: To assess human papillomavirus (HPV) vaccination coverage after
demonstration projects conducted in India, Peru, Uganda and Viet Nam by PATH and …

[HTML][HTML] Human papillomavirus vaccination coverage among school girls in a demonstration project-Botswana, 2013

MM Raesima, SE Forhan, AC Voetsch, S Hewitt… - MMWR Morb Mortal …, 2015 - cdc.gov
Cervical cancer, caused by human papillomavirus (HPV), is the leading cause of cancer
mortality among women in Botswana (1). Three vaccines prevent infection with HPV types …

Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability–HPV vaccine demonstration program, Cambodia …

J Garon, IV Wuddhika, N Sreenivasan… - Vaccine, 2019 - Elsevier
Abstract Background In 2017, the Cambodia Ministry of Health introduced human
papillomavirus (HPV) vaccine through primarily school-based vaccination targeting 9-year …